Net Medical (OTCMKTS:NMXS) Stock Extends Rally: Jumps 14% In a Week
Net Medical (OTCMKTS:NMXS) is up 6% and 14% in a week. The company has announced that it will launch a new product line of supplements under the Immunity Science brand providing immune system boosting vitamins. In addition, immunity Sciences will sell various anti-inflammatory supplements and a specialized gummies product line on www.immunityscience.store website expected to launch at the end of March.
Market Stats
On Monday, NMXS stock moved up 6.25% to $0.0850 with more than 24.5k shares, compared to its average volume of 19K shares. The stock moved within a range of $0.0850 – 0.0989 after opening trading at $0.0989.
Net Medical to Launch New Supplement Line to Boost Immune Systems; Specifically Targets Colds, Flu, Inflammation and Cell Mutations
Zinc, quercetin, and vitamin C and D will be included in the lineup. Several studies have demonstrated that such supplements can help the immune system fight inflammatory conditions and widespread viruses like colds, flu, and other disorders. For example, quercetin has demonstrated the ability to lower infection and inflammatory risk.
On the other hand, Vitamin D has been shown in recent Israeli research to minimize the risk of major disease or death due to Covid-19. Equally, zinc has also been considered as a bullet in fighting against COVID-19 infection. So, NMXS is worth watching in the coming weeks.
Key Quote
Net Medical CEO Dick Govatski said, “The Covid pandemic has created new awareness about both the need and ability of individuals to take steps to protect their own health. The rapid growth of our Covid testing business has introduced us to a large underserved market of consumers who have a fresh awareness of the threats to their health.
Traders Corner
NMXS stock is trading above the 20-Day and 50-Day Moving averages of $0.0717 and $0.0677 respectively. Moreover, the stock is trading above the 200-Day moving average of $0.0581.
